South Korean Biotech Breakthroughs

Results

0 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

2 companies

HansBiomed

Market Cap: ₩445.0b

Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.

A042520

₩29,400.00

-7.8%

306.1%

3billion

Market Cap: ₩437.4b

Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.

A394800

₩13,510.00

8.0%

101.9%